(NASDAQ: PDSB) Pds Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.92%.
Pds Biotechnology's earnings in 2025 is -$36,602,185.On average, 5 Wall Street analysts forecast PDSB's earnings for 2025 to be -$39,162,697, with the lowest PDSB earnings forecast at -$43,872,667, and the highest PDSB earnings forecast at -$36,234,122. On average, 5 Wall Street analysts forecast PDSB's earnings for 2026 to be -$34,564,648, with the lowest PDSB earnings forecast at -$41,130,625, and the highest PDSB earnings forecast at -$28,399,717.
In 2027, PDSB is forecast to generate -$36,942,949 in earnings, with the lowest earnings forecast at -$46,157,702 and the highest earnings forecast at -$31,827,270.